Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease

• Shyra J. Gardai ,

  * E-mail: sgardai@gmail.com

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• Wenxian Mao,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• Birgitt Schüle,

  Affiliation The Parkinson's Institute, Sunnyvale, California, United States of America

  ⨯
• Michael Babcock,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• Sue Schoebel,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• Carlos Lorenzana,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• Jeff Alexander,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• Sam Kim,

  Affiliation The Parkinson's Institute, Sunnyvale, California, United States of America

  ⨯
• Heather Glick,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• Kathryn Hilton,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• J. Kent Fitzgerald,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• Manuel Buttini,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• San-San Chiou,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• Lisa McConlogue,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• John P. Anderson,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• Dale B. Schenk,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• Frederique Bard,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• J. William Langston,

  Affiliation The Parkinson's Institute, Sunnyvale, California, United States of America

  ⨯
• Ted Yednock,

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
•  [ ... ],
• Jennifer A. Johnston

  Affiliation Elan Pharmaceuticals, Research, South San Francisco, California, United States of America

  ⨯
• [ view all ]
• [ view less ]